10Munoz M, Garcfa-Erce JA, Campos A, Femando Barrios L. [Legal framework for the use of autologous blood and other alternatives to allogenic transfusion] Med Clin (Barc) 2007; 128:256-262. 被引量：1
5Hendrickson JE,Hillyer CD.Noninfectious serious hazards of transfusion[J].Anesth Analg,2009,108(3):759-769. 被引量：1
6Panning R.Process-improvement methods mean bestpractice performance[J].MLO:Medical Laboratory Observer,2006(5):24-27. 被引量：1
7Nishizawa T,okamoto H,Konishi K.A novel DNA Virus(TTV)associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology[J].Bichem Biophys Rescommun,2007(1):92-93. 被引量：1
8Busch MP,Keinman SH,Jackson B.Nucleic acid amp lification testing of blood donors for transfusion transmitted infectious diseases Report of interorganizational force on nucleic acid amp lification testing of blood donors[J].Transfusion,2009(2):143-159. 被引量：1
9Dzik WS,Beckman N,Selleng K,et al.Errors in patient specimen collection:application of statistical process control[J].Transfusion,2008,48(10):2143-2151. 被引量：1
